Induced Pluripotent Stem Cells Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
세계의 유도만능줄기세포(iPS 세포) 시장 규모는 2025년 32억 달러에 이르고, 2025-2032년의 예측 기간 동안 7.50%의 연평균 복합 성장률(CAGR)로 확대되어 2032년에는 53억 달러에 달할 전망입니다.
세계 iPS 세포 시장은 약물 테스트, 질병 모델링, 재생 의학 및 독성 테스트에 사용되는 특수 세포 유형을 생성하는 능력으로 인해 널리 중요성이 증가하고 있는 iPSC에 초점을 맞추었습니다. 이 시장은 줄기세포 연구의 지속적인 발전과 생명과학에 대한 투자 증가의 영향을 받고 있습니다. 향후 시장 성장은 질병 발견, 신약 개발 및 맞춤 의료에서 iPSC의 역할에 대한 이해에 초점을 맞추는 학술 및 상업 기관에 의해 촉진될 것입니다.
세계 iPS 세포 시장은 다양한 요인으로 인해 크게 성장하고 있습니다. 특히 재생의료와 질병 모델링에 대한 관심이 높아지고 있습니다. 줄기세포를 이용한 치료에 집중하는 기업이 늘어남에 따라 iPS 세포에 대한 수요도 증가할 것으로 예상됩니다. 또한, iPSC 기술의 발전으로 약물 스크리닝의 효율성이 높아져 동물 모델에 대한 의존도가 낮아지고 전임상시험이 개선되고 있습니다. 또한, 북미와 유럽에서 진행되고 있는 연구와 환자 특이적 약물 스크리닝에 iPSC를 사용하려는 움직임이 증가하고 있는 것도 시장 확대를 견인하고 있습니다. 또한, iPSC를 통해 환자별 질병 모델링과 약물 임상시험이 가능해짐에 따라 개인맞춤형 의료에 대한 수요도 시장 성장에 더욱 탄력을 받을 것으로 예상됩니다.
iPS 세포 시장은 특히 생명공학 및 제약 산업의 지속적인 성장과 함께 큰 기회를 제공합니다. iPS 세포는 질병 메커니즘이 밝혀지면서 개인 맞춤형 의약품 개발 및 질병 치료에 독특한 기회를 제공합니다. 특히 대학과 연구기관의 기초연구에 대한 추가 투자는 iPSC를 어떻게 활용하면 질병 과정을 더 깊이 이해할 수 있는지에 대한 새로운 통찰력을 제공하여 새로운 치료 전략으로 이어질 수 있을 것으로 기대됩니다. 또한, 독성시험과 임상시험에서 iPSC의 사용 확대는 큰 성장 기회를 제공할 것입니다. 생명공학 기업과 연구기관의 협력은 시장 잠재력을 더욱 높이고 iPSC 기반 응용 분야의 상용화를 가속화하고 있습니다.
이 보고서는 전 세계 인공만능줄기세포(iPS 세포) 시장을 조사했으며, 세포 유형별, 용도별, 최종사용자별, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.
목차
제1장 주요 요약
제2장 시장 서론
제3장 유도만능줄기세포 시장 기회 분석
제4장 시장 배경
제5장 거시경제 전제
제6장 세계 경제 전망
제7장 주요 내용
제8장 북미의 유도만능줄기세포(iPS 세포) 시장 분석(2020년-2024년) 및 예측(2025년-2032년)
제9장 라틴아메리카의 유도만능줄기세포(iPS 세포) 시장 분석(2020년-2024년) 및 예측(2025년-2032년)
제10장 유럽의 유도만능줄기세포(iPS 세포) 시장 분석(2020년-2024년) 및 예측(2025년-2032년)
제11장 아시아태평양의 유도만능줄기세포(iPS 세포) 시장 분석(2020년-2024년) 및 예측(2025년-2032년)
제12장 중국의 유도만능줄기세포(iPS 세포) 시장 분석(2020년-2024년) 및 예측(2025년-2032년)
제13장 중동 및 아프리카의 유도만능줄기세포(iPS 세포) 시장 분석(2020년-2024년) 및 예측(2025년-2032년)
제14장 예측 요인 : 관련성과 영향
제15장 예측의 전제조건
제16장 시장 구조 분석
제17장 경쟁 분석
- 경쟁 대시보드
- 경쟁 벤치마킹
- 기업 상세
- Thermo Fisher Scientific Inc.
- FUJIFILM Holdings Corporation(Cellular Dynamics)
- Horizon Discovery Group plc.
- Takara Bio Inc.
- Cell Applications, Inc.
- Lonza Group Ltd.
제18장 세계의 유도만능줄기세포(iPS 세포) 시장 분석(2020년-2024년) 및 예측(2025년-2032년), 지역별
제19장 세계의 유도만능줄기세포 분석(2020년-2024년) 및 예측(2025년-2032년), 세포 유형별
제20장 세계의 유도만능줄기세포(iPS 세포) 시장 분석(2020년-2024년) 및 예측(2025년-2032년), 용도별
제21장 세계의 유도만능줄기세포(iPS 세포) 시장 분석(2020년-2024년) 및 예측(2025년-2032년), 최종사용자별
제22장 세계의 유도만능줄기세포(iPS 세포) 시장 분석(2020년-2024년) 및 예측(2025년-2032년)
제23장 가정과 두자어
제24장 조사 방법
LSH
Persistence Market Research has recently released a comprehensive report on the global iPS Cell Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.
Key Insights:
- Induced Pluripotent Stem Cell Market Size (2025E): USD 3.2 Billion
- Projected Market Value (2032F): USD 5.3 Billion
- Global Market Growth Rate (CAGR 2025 to 2032): 7.50%
Induced Pluripotent Stem Cell Market- Report Scope:
The global iPS cell market is focused on induced pluripotent stem cells (iPSCs), which are gaining widespread importance for their ability to generate specialized cell types used for drug testing, disease modeling, regenerative medicine, and toxicity testing. This market is influenced by ongoing advancements in stem cell research and increasing investments in life sciences. The market's future growth is fueled by both academic and commercial entities' focus on understanding the roles of iPSCs in disease development, drug discovery, and personalized medicine.
Market Drivers:
The global iPS cell market is witnessing significant growth due to various factors. A key driver is the increasing investment in life science research, particularly the growing emphasis on regenerative medicine and disease modeling. With more companies focusing on stem cell-based therapies, the demand for iPSCs is expected to rise. In addition, advancements in iPSC technology have made drug screening more efficient, reducing the reliance on animal models and improving preclinical testing. Moreover, the ongoing research in North America and Europe, as well as the rising use of iPSCs for patient-specific drug screening, supports the expansion of the market. The demand for personalized medicine is also expected to provide further momentum to market growth, as iPSCs allow for patient-specific disease modeling and drug testing.
Market Restraints:
Despite the promising growth trajectory, the iPS cell market faces some hurdles. One of the primary challenges is the complexity and cost associated with iPSC production and maintenance, which may limit accessibility for smaller research institutions or emerging biotech firms. Additionally, ethical concerns surrounding stem cell research, along with stringent regulatory frameworks, can impede market expansion. There is also a need for improved standardization and protocols in iPSC generation, differentiation, and application to ensure consistency and reproducibility in research. These challenges are expected to be addressed through ongoing research, technological improvements, and evolving regulatory support.
Market Opportunities:
The iPS cell market offers substantial opportunities, particularly with the continued growth of the biotechnology and pharmaceutical industries. With an increased understanding of disease mechanisms, iPSCs offer unique opportunities for personalized drug development and disease treatment. Further investment in basic research, especially in academia and research institutes, is expected to provide fresh insights into how iPSCs can be used to better understand disease processes, leading to new therapeutic strategies. Additionally, the growing use of iPSCs in toxicity testing and clinical trials presents significant growth opportunities. The increasing collaboration between biotech firms and research institutes further enhances market potential, accelerating the commercialization of iPSC-based applications.
Key Questions Answered in the Report:
- What are the primary factors driving the global growth of the iPS cell market?
- How are advancements in stem cell technology influencing iPS cell-based applications?
- Which regions are seeing the highest demand for iPS cells in drug testing, regenerative medicine, and toxicity screening?
- What are the challenges and limitations associated with iPSC technology, and how can these be overcome?
- Who are the key players in the iPS cell market, and what strategies are they employing to expand their market presence?
- What are the emerging trends and future projections for the global iPS cell market?
Competitive Intelligence and Business Strategy:
Leading companies in the global iPS cell market are focusing on enhancing their research capabilities and expanding product portfolios. Key players such as FUJIFILM Cellular Dynamics, Stemcell Technologies, and ReproCELL are investing heavily in advancing iPSC technologies and developing solutions tailored to drug discovery and regenerative medicine. Strategic partnerships and collaborations with academic institutions and research organizations play a critical role in accelerating product development and market reach. These companies are also exploring innovative applications of iPSCs in disease modeling and personalized treatments, positioning themselves as leaders in the expanding life sciences field.
Key Companies Profiled:
- Thermo Fisher Scientific Inc.
- FUJIFILM Holdings Corporation (Cellular Dynamics)
- Horizon Discovery Group plc.
- Takara Bio Inc.
- Cell Applications, Inc.
- Lonza Group Ltd.
- Others.
Induced Pluripotent Stem Cell Market Segmentation:
By Cell Type:
- Hepatocytes
- Fibroblasts
- Keratinocytes
- Neurons
- Others
By Application:
- Drug Development
- Regenerative Medicine
- Toxicity Testing
By End User:
- Academic and Research Institutes
- Biotechnology Companies
By Region:
- North America
- Latin America
- Europe
- Asia Pacific excluding China (APEC)
- China
- Middle East and Africa (MEA)
Table of Contents
1. Executive Summary
- 1.1. Market Overview
- 1.2. Market Analysis
- 1.3. PMR Analysis and Recommendations
- 1.4. Wheel of Fortune
2. Market Introduction
- 2.1. Market Definition
- 2.2. Market Taxonomy
3. Induced Pluripotent Stem cells Market Opportunity Analysis
- 3.1. Macro-Economic Factors
- 3.2. Opportunity Analysis
4. Market Background
- 4.1. Parent Market Overview
- 4.2. Induced Pluripotent Stem Cell Timeline
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Trends
5. Macroeconomic Assumptions
6. Global Economic Outlook
- 6.1. Gross Domestic Product by Region & Country, 2025 - 2032
- 6.2. Healthcare Indicators
7. Key Inclusions
- 7.1. Usage Trend in Industry
- 7.2. Active Researchers in Stem Cell Research
- 7.3. Induced Pluripotent Stem Cell Therapy for Cardiovascular Disease
- 7.4. In-Vivo Modelling for Neurological Disorder Using Induced Pluripotent Stem Cells
- 7.5. Pipeline Assessment
8. North America Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032
- 8.1. Introduction
- 8.2. Regional Market Trends
- 8.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
- 8.3.1. U.S.
- 8.3.2. Canada
- 8.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
- 8.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
- 8.5.1. Hepatocytes
- 8.5.2. Fibroblasts
- 8.5.3. Keratinocytes
- 8.5.4. Neurons
- 8.5.5. Others
- 8.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
- 8.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
- 8.7.1. Drug Development
- 8.7.2. Toxicity testing
- 8.7.3. Regenerative Medicine
- 8.7.4. Others
- 8.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
- 8.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
- 8.9.1. Academic & Research Institutes
- 8.9.2. Biotechnology companies
- 8.9.3. Others
- 8.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
- 8.11. Drivers and Restraints: Impact Analysis
- 8.12. Market Attractiveness Analysis
- 8.12.1. By Country
- 8.12.2. By Cell Type
- 8.12.3. By Application
- 8.12.4. By End User
- 8.13. Key Market Participants - Intensity Mapping
- 8.14. Drivers and Restraints - Impact Analysis
9. Latin America Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032
- 9.1. Introduction
- 9.2. Regional Market Trends
- 9.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
- 9.3.1. Argentina
- 9.3.2. Brazil
- 9.3.3. Mexico
- 9.3.4. Rest of Latin America
- 9.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
- 9.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
- 9.5.1. Hepatocytes
- 9.5.2. Fibroblasts
- 9.5.3. Keratinocytes
- 9.5.4. Neurons
- 9.5.5. Others
- 9.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
- 9.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
- 9.7.1. Drug Development
- 9.7.2. Toxicity testing
- 9.7.3. Regenerative Medicine
- 9.7.4. Others
- 9.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
- 9.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
- 9.9.1. Academic & Research Institutes
- 9.9.2. Biotechnology companies
- 9.9.3. Others
- 9.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
- 9.11. Drivers and Restraints: Impact Analysis
- 9.12. Market Attractiveness Analysis
- 9.12.1. By Country
- 9.12.2. By Cell Type
- 9.12.3. By Application
- 9.12.4. By End User
- 9.13. Key Market Participants - Intensity Mapping
- 9.14. Drivers and Restraints - Impact Analysis
- 9.15. Key Mergers & Acquisitions
10. Europe Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032
- 10.1. Introduction
- 10.2. Regional Market Trends
- 10.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
- 10.3.1. Germany
- 10.3.2. U.K.
- 10.3.3. France
- 10.3.4. Italy
- 10.3.5. Spain
- 10.3.6. Russia
- 10.3.7. Rest of Europe
- 10.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
- 10.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
- 10.5.1. Hepatocytes
- 10.5.2. Fibroblasts
- 10.5.3. Keratinocytes
- 10.5.4. Neurons
- 10.5.5. Others
- 10.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
- 10.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
- 10.7.1. Drug Development
- 10.7.2. Toxicity testing
- 10.7.3. Regenerative Medicine
- 10.7.4. Others
- 10.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
- 10.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
- 10.9.1. Academic & Research Institutes
- 10.9.2. Biotechnology companies
- 10.9.3. Others
- 10.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
- 10.11. Drivers and Restraints: Impact Analysis
- 10.12.Market Attractiveness Analysis
- 10.12.1. By Country
- 10.12.2. By Cell Type
- 10.12.3. By Application
- 10.12.4. By End User
- 10.13. Key Market Participants - Intensity Mapping
- 10.14. Drivers and Restraints - Impact Analysis
- 10.15. Key Mergers & Acquisitions
11. Asia Pacific Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032
- 11.1. Introduction
- 11.2. Regional Market Trends
- 11.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
- 11.3.1. Japan
- 11.3.2. India
- 11.3.3. Australia and New Zealand
- 11.3.4. Rest of Asia Pacific
- 11.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
- 11.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
- 11.5.1. Hepatocytes
- 11.5.2. Fibroblasts
- 11.5.3. Keratinocytes
- 11.5.4. Neurons
- 11.5.5. Others
- 11.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
- 11.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
- 11.7.1. Drug Development
- 11.7.2. Toxicity testing
- 11.7.3. Regenerative Medicine
- 11.7.4. Others
- 11.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
- 11.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
- 11.9.1. Academic & Research Institutes
- 11.9.2. Biotechnology companies
- 11.9.3. Others
- 11.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
- 11.11. Drivers and Restraints: Impact Analysis
- 11.12. Market Attractiveness Analysis
- 11.12.1. By Country
- 11.12.2. By Cell Type
- 11.12.3. By Application
- 11.12.4. By End User
- 11.13. Key Market Participants - Intensity Mapping
- 11.14. Drivers and Restraints - Impact Analysis
- 11.15. Key Mergers & Acquisitions
12. China Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032
- 12.1. Introduction
- 12.2. Key Regulations
- 12.3. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
- 12.3.1. Hepatocytes
- 12.3.2. Fibroblasts
- 12.3.3. Keratinocytes
- 12.3.4. Neurons
- 12.3.5. Others
- 12.4. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
- 12.5. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
- 12.5.1. Drug Development
- 12.5.2. Toxicity testing
- 12.5.3. Regenerative Medicine
- 12.5.4. Others
- 12.6. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
- 12.7. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
- 12.7.1. Academic & Research Institutes
- 12.7.2. Biotechnology companies
- 12.7.3. Others
- 12.8. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
- 12.9. Drivers and Restraints: Impact Analysis
- 12.10. Market Attractiveness Analysis
- 12.10.1. By Cell Type
- 12.10.2. By Application
- 12.10.3. By End User
- 12.11. Key Market Participants - Intensity Mapping
- 12.12. Drivers and Restraints - Impact Analysis
- 12.13. Key Mergers & Acquisitions
13. Middle East & Africa Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032
- 13.1. Introduction
- 13.2. Key Regulations
- 13.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
- 13.3.1. GCC Countries
- 13.3.2. South Africa
- 13.3.3. Rest of MEA
- 13.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
- 13.5. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
- 13.5.1. Hepatocytes
- 13.5.2. Fibroblasts
- 13.5.3. Keratinocytes
- 13.5.4. Neurons
- 13.5.5. Others
- 13.6. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
- 13.7. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
- 13.7.1. Drug Development
- 13.7.2. Toxicity testing
- 13.7.3. Regenerative Medicine
- 13.7.4. Others
- 13.8. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
- 13.9. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
- 13.9.1. Academic & Research Institutes
- 13.9.2. Biotechnology companies
- 13.9.3. Others
- 13.10. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
- 13.11. Drivers and Restraints: Impact Analysis
- 13.12. Market Attractiveness Analysis
- 13.12.1. By Country
- 13.12.2. By Cell Type
- 13.12.3. By Application
- 13.12.4. By End User
- 13.13. Key Market Participants - Intensity Mapping
- 13.14. Drivers and Restraints - Impact Analysis
- 13.15. Key Mergers & Acquisitions
14. Forecast Factors: Relevance and Impact
15. Forecast Assumptions
16. Market Structure Analysis
- 16.1. Market Structure by Tier of Companies
- 16.2. Market Share Analysis (2024) for Top Players, By Region
17. Competition Analysis
- 17.1. Competition Dashboard
- 17.2. Competition Benchmarking
- 17.3. Company Deep Dive
- 17.3.1. Thermo Fisher Scientific Inc.
- 17.3.1.1. Overview
- 17.3.1.2. Product and Application Portfolio
- 17.3.1.3. Production Footprint
- 17.3.1.4. Sales Footprint
- 17.3.1.5. Channel Footprint
- 17.3.1.6. Strategy
- 17.3.1.6.1. Marketing Strategy
- 17.3.1.6.2. Product Strategy
- 17.3.1.6.3. Channel Strategy
- 17.3.2. FUJIFILM Holdings Corporation (Cellular Dynamics)
- 17.3.2.1. Overview
- 17.3.2.2. Product and Application Portfolio
- 17.3.2.3. Production Footprint
- 17.3.2.4. Sales Footprint
- 17.3.2.5. Channel Footprint
- 17.3.2.6. Strategy
- 17.3.2.6.1. Marketing Strategy
- 17.3.2.6.2. Product Strategy
- 17.3.2.6.3. Channel Strategy
- 17.3.3. Horizon Discovery Group plc.
- 17.3.3.1. Overview
- 17.3.3.2. Product and Application Portfolio
- 17.3.3.3. Production Footprint
- 17.3.3.4. Sales Footprint
- 17.3.3.5. Channel Footprint
- 17.3.3.6. Strategy
- 17.3.3.6.1. Marketing Strategy
- 17.3.3.6.2. Product Strategy
- 17.3.3.6.3. Channel Strategy
- 17.3.4. Takara Bio Inc.
- 17.3.4.1. Overview
- 17.3.4.2. Product and Application Portfolio
- 17.3.4.3. Production Footprint
- 17.3.4.4. Sales Footprint
- 17.3.4.5. Channel Footprint
- 17.3.4.6. Strategy
- 17.3.4.6.1. Marketing Strategy
- 17.3.4.6.2. Product Strategy
- 17.3.4.6.3. Channel Strategy
- 17.3.5. Cell Applications, Inc.
- 17.3.5.1. Overview
- 17.3.5.2. Product and Application Portfolio
- 17.3.5.3. Production Footprint
- 17.3.5.4. Sales Footprint
- 17.3.5.5. Channel Footprint
- 17.3.5.6. Strategy
- 17.3.5.6.1. Marketing Strategy
- 17.3.5.6.2. Product Strategy
- 17.3.5.6.3. Channel Strategy
- 17.3.6. Lonza Group Ltd.
- 17.3.6.1. Overview
- 17.3.6.2. Product and Application Portfolio
- 17.3.6.3. Production Footprint
- 17.3.6.4. Sales Footprint
- 17.3.6.5. Channel Footprint
- 17.3.6.6. Strategy
- 17.3.6.6.1. Marketing Strategy
- 17.3.6.6.2. Product Strategy
- 17.3.6.6.3. Channel Strategy
18. Global Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032, By Region
- 18.1. Introduction/Key Findings
- 18.2. Historical Market Size (US$ Bn) Trend Analysis By Region, 2020 - 2024
- 18.3. Market Size (US$ Bn) Forecast By Region, 2025 - 2032
- 18.3.1. North America
- 18.3.2. Latin America
- 18.3.3. Europe
- 18.3.4. Asia Pacific
- 18.3.5. Middle East & Africa
- 18.3.6. China
- 18.4. Market Attractiveness Analysis By Region
19. Global Induced Pluripotent Stem Cells Analysis 2020 - 2024 and Forecast 2025 - 2032, By Cell Type
- 19.1. Introduction/Key Findings
- 19.2. Historical Market Size (US$ Bn) Trend Analysis By Cell Type, 2020 - 2024
- 19.2.1. Hepatocytes
- 19.2.2. Fibroblasts
- 19.2.3. Keratinocytes
- 19.2.4. Neurons
- 19.2.5. Others
- 19.3. Market Size (US$ Bn) Forecast By Cell Type, 2025 - 2032
- 19.4. Market Attractiveness Analysis By Cell Type
20. Global Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032, By Application
- 20.1. Introduction/Key Findings
- 20.2. Historical Market Size (US$ Bn) Trend Analysis By Application, 2020 - 2024
- 20.2.1. Drug Development
- 20.2.2. Toxicity testing
- 20.2.3. Regenerative Medicine
- 20.2.4. Others
- 20.3. Market Size (US$ Bn) Forecast By Application, 2025 - 2032
- 20.4. Market Attractiveness Analysis By Application
21. Global Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032, By End User
- 21.1. Introduction/Key Findings
- 21.2. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
- 21.2.1. Academic & Research Institutes
- 21.2.2. Biotechnology companies
- 21.2.3. Others
- 21.3. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
- 21.4. Market Attractiveness Analysis By End User
22. Global Induced Pluripotent Stem Cells Market Analysis 2020 - 2024 and Forecast 2025 - 2032
- 22.1. Market Value Share Analysis By All Segment
- 22.2. Y-o-Y Growth Analysis By All Segment
- 22.3. Absolute $ Opportunity
23. Assumptions and Acronyms
24. Research Methodology
